UnknownNot Applicable

Prevalence,Natural History,Prognosis Factor,QualityofLife,Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France

France878 participantsStarted 2007-04

Plain-language summary

The aim of the project is to assemble and to follow on a 10-year period a nationwide representative sample of lower limb OA patients. General objectives: To document the natural history and to identify predictive factors of the evolution and consequences of hip and knee OA in terms of pain, functional disability, structural damage, quality of life, autonomy, medical and health care use and cost of disease.

Who can participate

Age range40 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * male and female aged between 40 and 75 years * symptomatic hip or knee, uni or bilateral OA with clinical diagnosis confirmed by a medical physician and satisfying ACR classification criteria * Representative of prevalent cases in France at the cohort set-up time Exclusion Criteria: * presence of hip or knee joint replacement surgery * comorbidities severe enough to affect quality of life significantly or likely to induce a high health care consumption independently of OA * an history of osteotomy * Patello-femoral osteoarthritis without tibio-femoral osteoarthritis * Other joint diseases of the target joints * adult under legal protection or not able to consent

What they're measuring

Quality of life, patient reported outcome measures

Timeframe: every year, up to 10 years

Trial details

NCT IDNCT00481338

SponsorCentral Hospital, Nancy, France

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03

View on ClinicalTrials.gov More Hip Osteoarthritis trials